Moneycontrol PRO
HomeNewsBusinessStocksCRISIL secures board approval for new step down subsidiary, shares see marginal dip

CRISIL secures board approval for new step down subsidiary, shares see marginal dip

The analytical ratings company will transfer the ESG Scores business of the company by way of business transfer agreement.

September 13, 2023 / 10:47 IST
CRISIL, a subsidiary of S&P Global, is an Indian analytical company providing ratings, research, and risk and policy advisory services

Shares of CRISIL opened 0.5 percent higher on the NSE, a day after it received approval from the board of directors to incorporate a step down subsidiary to carry out the business of an ESG Ratings provider. At open, the stock was trading at Rs 3,879.25, against yesterday's closing of Rs 3,856. However, as of 10 am, the shares fell to Rs 3849.35, down from yesterday’s close.

Follow our market blog for updates

The incorporation of CRISIL's proposed subsidiary, CRISIL ESG Ratings & Analytics Limited, according to a filing is subject to approvals from "SEBI and other authorities." The analytical ratings company will transfer the ESG Scores business of the company by way of business transfer agreement.

Additionally, the subsidiary CRISIL Irevna UK has approved the incorporation of a wholly owned subsidiary - Crisil Irevna Information Technology Colombia SAS in Colombia.

On September 12, CRISIL also received approval from its board for acquisition of 100 percent equity in Bridge to India Energy Private Limited at Rs 6 crore. Bridge to India provides clients 360-degree insights into the renewable energy market founded on deep domain expertise and a comprehensive set of databases and tools.

For the quarter ending June 2023, CRISIL reported 15.33 percent year-on-year increase in net sales to Rs 771.02 crore in June 2023 from the previous fiscal. Net Profit also grew 9.99 percent year-on-year  Rs. 150.58 crore for the same period. For the June 2023 quarter. the Indian rating agency reported earnings before interest, depreciation and amortisation (EBIDTA) at Rs. 221.90 crore, up from Rs. 204.43 crore in June 2022.

Also read: Indian pharma industry to log in 8-10% revenue growth this fiscal: Crisil

CRISIL, a subsidiary of S&P Global, is an Indian analytical company providing ratings, research, and risk and policy advisory services.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Moneycontrol News
first published: Sep 13, 2023 10:24 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347